Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Assets (2017 - 2022)

Historic Assets for Iterum Therapeutics (ITRM) over the last 6 years, with Q3 2022 value amounting to $71.6 million.

  • Iterum Therapeutics' Assets fell 2729.78% to $71.6 million in Q3 2022 from the same period last year, while for Sep 2022 it was $71.6 million, marking a year-over-year decrease of 2729.78%. This contributed to the annual value of $91.5 million for FY2021, which is 17905.89% up from last year.
  • Per Iterum Therapeutics' latest filing, its Assets stood at $71.6 million for Q3 2022, which was down 2729.78% from $76.7 million recorded in Q2 2022.
  • Over the past 5 years, Iterum Therapeutics' Assets peaked at $145.5 million during Q2 2018, and registered a low of $25.8 million during Q4 2019.
  • Over the past 5 years, Iterum Therapeutics' median Assets value was $80.4 million (recorded in 2022), while the average stood at $76.3 million.
  • Its Assets has fluctuated over the past 5 years, first plummeted by 7368.88% in 2019, then skyrocketed by 27465.55% in 2021.
  • Iterum Therapeutics' Assets (Quarter) stood at $97.9 million in 2018, then crashed by 73.69% to $25.8 million in 2019, then increased by 27.34% to $32.8 million in 2020, then soared by 179.06% to $91.5 million in 2021, then dropped by 21.81% to $71.6 million in 2022.
  • Its last three reported values are $71.6 million in Q3 2022, $76.7 million for Q2 2022, and $84.1 million during Q1 2022.